PolyPeptide Group AG
SIX:PPGN.SW
31.95 (CHF) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CHF.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 95.706 | 37.528 | 136.303 | 17.208 | 17.508 | 10.037 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 95.706 | 37.528 | 136.303 | 17.208 | 17.508 | 10.037 |
| Net Receivables
| 101.073 | 49.146 | 67.789 | 55.538 | 35.449 | 42.369 |
| Inventory
| 128.507 | 145.073 | 113.001 | 94.269 | 73.49 | 72.334 |
| Other Current Assets
| 1.316 | 19.823 | 14.513 | 12.847 | 16.222 | 58.879 |
| Total Current Assets
| 326.602 | 251.57 | 331.606 | 179.862 | 142.669 | 141.25 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 324.105 | 297.294 | 235.442 | 169.808 | 136.635 | 115.802 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 16.454 | 15.865 | 14.268 | 12.556 | 12.312 | 10.91 |
| Goodwill and Intangible Assets
| 16.454 | 15.865 | 14.268 | 12.556 | 12.312 | 10.91 |
| Long Term Investments
| 5.237 | 2.767 | 3.467 | 0.201 | 0.459 | 3.251 |
| Tax Assets
| 16.69 | 8.286 | 10.255 | 13.548 | 13.067 | 12.613 |
| Other Non-Current Assets
| 0 | -8.286 | -10.255 | -13.548 | 0 | 0 |
| Total Non-Current Assets
| 362.486 | 315.926 | 253.177 | 182.565 | 162.473 | 142.576 |
| Total Assets
| 689.088 | 575.782 | 595.038 | 375.975 | 305.142 | 283.826 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 60.906 | 45.933 | 28.481 | 28.359 | 18.46 | 14.731 |
| Short Term Debt
| 45.706 | 3.566 | 3.058 | 1.979 | 1.491 | 18.264 |
| Tax Payables
| 9.304 | 4.853 | 7.576 | 13.762 | 8.236 | 2.297 |
| Deferred Revenue
| 68.447 | -3.566 | -3.058 | -1.979 | 34.991 | 2.297 |
| Other Current Liabilities
| 1.391 | 50.119 | 75.48 | 73.489 | 1.36 | 28.652 |
| Total Current Liabilities
| 176.45 | 96.052 | 103.961 | 101.848 | 56.302 | 63.944 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 67.956 | 9.41 | 10.302 | 35.902 | 33.869 | 25 |
| Deferred Revenue Non-Current
| 23.16 | 7.532 | 9.196 | 35.026 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 3.644 | 1.878 | 1.106 | 0.876 | 1.121 | 2.149 |
| Other Non-Current Liabilities
| 36.653 | -9.41 | -10.302 | -35.902 | 64.434 | 45.059 |
| Total Non-Current Liabilities
| 131.413 | 9.41 | 10.302 | 35.902 | 99.424 | 72.208 |
| Total Liabilities
| 307.863 | 154.105 | 173.865 | 198.315 | 155.726 | 136.152 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 5.616 | 2.694 | 2.442 |
| Common Stock
| 0.302 | 0.302 | 0.302 | 33 | 33 | 50 |
| Retained Earnings
| 165.139 | 214.146 | 196.027 | 147.936 | 116.77 | 98.176 |
| Accumulated Other Comprehensive Income/Loss
| 23.049 | 17.709 | 13.231 | -5.616 | -2.694 | -2.442 |
| Other Total Stockholders Equity
| 192.735 | 189.52 | 211.613 | -3.276 | -0.354 | -0.502 |
| Total Shareholders Equity
| 381.225 | 421.677 | 421.173 | 177.66 | 149.416 | 147.674 |
| Total Equity
| 381.225 | 421.677 | 421.173 | 177.66 | 149.416 | 147.674 |
| Total Liabilities & Shareholders Equity
| 689.088 | 575.782 | 595.038 | 375.975 | 305.142 | 283.826 |